Table 1. Clinical characteristics of patients and molecular data of the corresponding tumor.

Tumor-ID	Age/Gender	Tumor location	TNM-Stage	Tumor type	Molecular type
HROC18	65/f	caecum	G2T2N0M0	primary adenocarcinoma	spStd
HROC24	98/m	colon ascendens	G2T2N0M0	primary adenocarcinoma	spMMR-D
HROC32	83/f	colon ascendens	G2T4N2M1	primary adenocarcinoma	spStd
HROC40	69/m	colon ascendens	G3T4N0M0	primary adenocarcinoma	CIMP-H
HROC60	71/m	colon ascendens	G2T2N0M0	primary adenocarcinoma	CIMP-H
HROC69	62/m	colon ascendens	G3T3NoMx	primary adenocarcinoma	spStd
HROC80	72/m	caecum	G2T3N2Mx	primary adenocarcinoma	spStd
HROC87	76/f	colon ascendens	G3T3N0M0	primary adenocarcinoma	spMMR-D
HROC107	81/f	colon ascendens	G3T3N0M0	primary adenocarcinoma	spMMR-D
HROC113	41/f	colon ascendens	G3T4N2Mx	primary adenocarcinoma	Lynch Syndrome

m – male, f – female, spStd – sporadic standard, spMMR-D – sporadic mismatch repair deficient, CIMP-H – CpG island methylator phenotype high, HNPCC – hereditary non-polyposis colorectal carcinoma